# Vardenafil ODT Versus Placebo in Males With Erectile Dysfunction

> **NCT00631969** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 362 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Vardenafil ODT (STAXYN, BAY38-9456)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00631969
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 362 (ACTUAL)
- **Last updated:** 2014-12-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00631969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00631969, "Vardenafil ODT Versus Placebo in Males With Erectile Dysfunction". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00631969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*